Dividend stocks shine as Fed hikes, yield gap narrows
Sam Stovall of S&P Capital IQ says dividend payers stay in play after the Fed’s Dec 16 rate rise. With the 10 year at about 2.25% and the S&P 500 yield near 2.10%, the narrow spread historically boosts returns. higher dividends remain a favored investor gift as bulls eye 2016 gains.
MENTIONED IN THIS ARTICLE
Federal Reserve
Sam Stovall
U.S. Equity
S&p Capital IQ
Fed
Stovall
Treasury Note
Standard & Poor
Treasury
U.S
Vanguard 500Admi
Vanguard Totstiadm
Vanguard Instldx
Vanguard TotStldx
Vanguard InstPlus
Fidelity Contra
GrthAmAm
Vanguard Totintl
IncAmerAm
CapiIncBuAm
Csvelsh
Bankrate.com
Ha Commodities
Clig
Frankfurt
Hong Kong
Japan
Nikkei
LonDon
Mexico City
Morningstar
THE
Associated Press
Usatoday.com
MONEY
Netflix Leads High Turnover Tech Stock Trades in December
SigFig data shows USA retail investors aggressively traded tech names with Netflix ranking top among the most bought and sold. The period highlights allocations leaning toward equities with Microsoft and Apple among largest holdings. a 6 month average suggests moderate stock activity across AAPL MSFT and other tech names while portfolio turnover exceeds 100 percent.
MENTIONED IN THIS ARTICLE
SigFig
Netflix
MSFT
AAPL
SigFig tops half a million investors online portfolios
SigFig reports more than 500000 investors nationwide managing portfolios online with total assets around 200 billion. The analysis on this page is based on SigFig data and reflects the platform's investment tracking service reach and scale.
MENTIONED IN THIS ARTICLE
America
SigFig
Walt Disney Star Wars hits $1B worldwide in record time
The Force Awakens repeats at No 1 in its second weekend with $153.5 million, pushing total global gross past $1 billion according to Rentrak estimates. In business news, the embattled drugmaker sails through CEO J Michael Pearson's medical leave after hospitalization for severe pneumonia.
MENTIONED IN THIS ARTICLE
J. Michael Pearson
Pearson
Walt Disney
Chimerix Lead Drug Fails Late-Stage Trial
Chimerix shares tumbled after its lead candidate for an infection in hematopoietic cell transplant patients failed to meet the primary endpoint in a pivotal trial. The company disclosed price movements and a significant decline in investor confidence following the setback.
MENTIONED IN THIS ARTICLE
Biotechnology
Investors weigh January Effect as small caps struggle early
Investors consider the January Effect as small company stocks lag at year start. The Stock Trader's Almanac notes shifts already beginning in November, with outperformance around mid December. If missed, concern eases as small caps often beat the market into May. Vanguard Small-Cap ETF drops 5.5% since end of November, vs SP 500 down 3.2%. Still, long-term, IFA US Small Company index posts 11.3% annual gain versus 9.8% for the S P 500.
MENTIONED IN THIS ARTICLE
Standard & Poor
IFA
Iconix Shares Dive After SEC Investigation Announced
Iconix Brand Group, known for Candie's Joe Boxer Rocawear and Danskin, saw its stock drop 24 percent to 5.67 after confirming a formal SEC investigation into accounting issues. The firm said it would cooperate and noted ongoing restatements for 2013 2014 and 2015 quarters and the formation of international joint ventures.
MENTIONED IN THIS ARTICLE
Iconix Brand Group
Candie’s
Joe Boxer
Rocawear
Danskin
Iconix
Securities and Exchange Com
SEC
Torical
Conix
Also Mentioned on This Page
MAJOR
Djia
DOW Jones
Ae PE
S&p 500
Standard & Poor's
Russell Russell
Google Axiom Capital
SWV
Southwestern Energy
SWN
Google
MAZON
Amazon.com
AMZN
Newell Rubbermaid
NWL
Blackrock
Hares Rise
Hewlett Packard Enterprise
HPE
UTC
ATA
Freeport-McMoRan
FCX
Bie
Consol Energy
CNX
Chesapeake Energy
CHE
Chesapeake
Marathon Oil
MRO
Ensco
ESV
Kinder Morgan
Transocean
RIG
Helmerich & Payne
USA
Valeant
Wace Denep
Chimerix
Investing
Matt
Matt Krantz
Mxrantz
USA Today